Company using MDMA to now treat post-traumatic stress

PERTH: Drug development company Emyria is eyeing a major expansion of its MDMA-assisted post-traumatic stress… read more
Doctors head for exit at PE-backed IVF player Genea

MELBOURNE: Liverpool Partners’ IVF provider Genea has lost four of its key fertility specialists over… read more
Mesoblast surges on FDA nod for its cell therapy

MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per cent after… read more
16 new senior healthcare executives sought for key roles

MELBOURNE: Sixteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more